Reliance submits proposal for niclosamide as potential drug against Covid
New Delhi, June 2 (IANS) Reliance Industries Limited (RIL) has submitted a proposal for the application of Niclosamide as a potential drug against Covid-19.
According to RIL’s annual report for FY20-21, the company is leveraging its intellectual capital to fight Covid-19, and its team is working with various CSIR laboratories to certify the Nexar polymer, which has demonstrated its ability to destroy the layer lipid of various viruses. and bacteria.
The annual report says Reliance’s R&D team has designed a process to produce disinfectants that meet WHO specifications at 20% market cost. Reliance has also developed new cost-effective diagnostic kits called “R-Green” and “R-Green Pro” for the detection of Covid-19. The kits have received approval from the ICMR, he said.
The company submitted a proposal for the application of Niclosamide as a potential drug against Covid-19.
Among other strengths, Reliance is working to address the inadequate supply of ventilators in Indian hospital emergency rooms by deploying a concept developed in Italy, which allows the use of a CPAP machine with a charlotte valve. 3D printed and a special snorkeling mask.
Reliance has forecasted a significant increase in on-site oxygen demand as the pandemic rages on, according to the report. He began work on a robust and economical design for oxygen generators capable of producing 5-7 liters of oxygen per minute with a purity of 90-95%.
Reliance has reached 100% O2C capacity utilization despite the pandemic, according to the report.
Reliance has also started the process of splitting its O2C activities into a separate subsidiary and the process is expected to be completed in 2021.
According to the annual report, the reorganization of O2C creates an independent growth engine on a global scale for RIL, with strong potential to generate cash flow while facilitating the creation of value through strategic partnerships and attracting a dedicated pool of investor capital.
During the Covid-19 crisis, Reliance operated its O2C facilities almost 100% by moving products to export markets to maintain operating rates.
The economy of scale along with strong competitive cost positions throughout the chain have helped Reliance maintain a positive contribution throughout this unprecedented phase. In addition, a diverse customer base, global product placement and commodity flexibility supported its performance.
The severe destruction of demand due to global bottlenecks has impacted O2C business. The flexibility of operations and the agile response to changing market dynamics have enabled operations to near normal levels and to achieve peak results. Domestic demand has picked up sharply across O2C activity, according to the report.
Reliance is also redefining fuel retailing through e-commerce in India. Reliance BP Mobility Limited (RBML) is the first petroleum marketing company (OMC) to obtain mobile distribution unit approval and the only OMC to use HDPE (non-metallic) containers for the delivery of fuel to the request.
With its services spanning all of India, it uncovers the latent needs of the non-transport sector and responds to those needs with high efficiency, paving the way for market leadership in the non-transport sector, according to the report.
san / arm